Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Blog

Bet on JNJ & Hold on to Apple to Grow Your Retirement Fund Stress-Free
Bet on JNJ & Hold on to Apple to Grow Your Retirement Fund Stress-Free

In a well-balanced retirement portfolio, investors should aim for a mix of defensive and growth stocks. This approach offers both stability and the potential for wealth creation over time. By

2025: The Year of Crypto Access & Regulation:
2025: The Year of Crypto Access & Regulation

The Crypto Industry Proves Resilient

Cryptocurrencies and the digital asset market have come a long way since an anonymous person or person (s) dubbed “Satoshi Nakamoto” released the 2008 Bitcoin

Can Cannabis Stocks Reverse Their Prolonged Downtrend?
Can Cannabis Stocks Reverse Their Prolonged Downtrend?

When Canada legalized recreational cannabis in 2018, many believed that the United States wouldn’t be far behind. Optimism grew further when the 2018 Farm Bill legalized hemp nationwide, fueling

Innodata's 375% EBITDA Jump Shows Operating Leverage: More to Come?Photo, wide shot, wide-angle lens,  Telecom equipment supplier, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/ad10ed87-71d0-4096-a50b-ba9470f8264b.png
Innodata's 375% EBITDA Jump Shows Operating Leverage: More to Come?

Innodata Inc. INOD delivered another standout quarter in the second quarter of 2025, with results underscoring its strong operating leverage and expanding role in the AI services ecosystem. Revenues

Consolidated Edison Q2 Earnings Beat Estimates, Revenues Rise Y/Y
Consolidated Edison Q2 Earnings Beat Estimates, Revenues Rise Y/Y

Consolidated Edison, Inc. ED reported second-quarter 2025 adjusted earnings of 67 cents per share, which topped the Zacks Consensus Estimate of 66 cents by 1.5%. The bottom line also improved 13.6%

Nebius' Q2 Loss Widens Y/Y, Revenues Rise on AI Demand, Stock UpPhoto, wide shot, wide-angle lens,  Semiconductor company, sunset photo at golden hour, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/92ce44e9-64c7-4458-9a95-b706ed510490.png
Nebius' Q2 Loss Widens Y/Y, Revenues Rise on AI Demand, Stock Up

Nebius Group N.V. NBIS reported second-quarter 2025 adjusted net loss of $91.5 million, 49% wider than a loss of $61.6 million incurred a year ago.

The company’s revenues surged 625% year over year

C3.ai's Generative AI Surge: A Catalyst for Fiscal 2026 Upside?Photo, wide shot, wide-angle lens,  Computer hardware manufacturer, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/ec495607-1e17-40ee-a41d-7726313a9707.png
C3.ai's Generative AI Surge: A Catalyst for Fiscal 2026 Upside?

C3.ai, Inc. AI closed fiscal 2025 with strong momentum, positioning its Generative AI and agentic AI platforms as central growth drivers for fiscal 2026. The company reported fiscal fourth-quarter

BBAI Pre-Q2 Preview: Tracking AI Adoption & Federal Contract MomentumPhoto, wide shot, wide-angle lens,  Software company, sunset photo at golden hour, photo by Peter Lik: https://img.midjourneyapi.xyz/temp/da273d82-9e59-413a-99b3-2b0094ff0854.png
BBAI Pre-Q2 Preview: Tracking AI Adoption & Federal Contract Momentum

BigBear.ai Holdings, Inc. BBAI is set to report second-quarter 2025 results on Aug. 11, with rising AI adoption and expanding federal contract momentum likely to be key performance drivers.

AI

BitFuFu Inc. (FUFU) Earnings Expected to Grow: Should You Buy?
BitFuFu Inc. (FUFU) Earnings Expected to Grow: Should You Buy?

BitFuFu Inc. (FUFU) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended June 2025. This widely-known consensus outlook gives

Analysts Estimate Flowers Foods (FLO) to Report a Decline in Earnings: What to Look Out for
Analysts Estimate Flowers Foods (FLO) to Report a Decline in Earnings: What to Look Out for

Wall Street expects a year-over-year decline in earnings on higher revenues when Flowers Foods (FLO) reports results for the quarter ended June 2025. While this widely-known consensus outlook is

SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
SurModics (SRDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

For the quarter ended June 2025, SurModics (SRDX) reported revenue of $29.57 million, down 2.6% over the same period last year. EPS came in at $0.06, compared to -$0.27 in the year-ago quarter.

The

5 Stocks in QQQ ETF That Drove Nasdaq's Record Closing High
5 Stocks in QQQ ETF That Drove Nasdaq's Record Closing High

The Nasdaq Composite closed at a record high on Aug. 7, even though new tariffs on imports from dozens of countries were implemented. With this, the index has posted 17 all-time closing highs in

Best Momentum Stock to Buy for August 8thPhoto, wide shot, wide-angle lens,  Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by David Maisel: https://img.theapi.app/temp/0e9d087d-988e-4397-b7cf-6049e2776769.png
Best Momentum Stock to Buy for August 8th

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, August 8th:

Rigel Pharmaceuticals RIGL:This clinical-stage drug development company that

Wall Street Analysts Believe Genmab (GMAB) Could Rally 33.8%: Here's is How to Trade
Wall Street Analysts Believe Genmab (GMAB) Could Rally 33.8%: Here's is How to Trade

Shares of Genmab A/S Sponsored ADR (GMAB) have gained 3.8% over the past four weeks to close the last trading session at $22.69, but there could still be a solid upside left in the stock if

How Much Upside is Left in Tidewater (TDW)? Wall Street Analysts Think 31.5%
How Much Upside is Left in Tidewater (TDW)? Wall Street Analysts Think 31.5%

Tidewater (TDW) closed the last trading session at $56.88, gaining 7.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street

How Much Upside is Left in Hesai Group Sponsored ADR (HSAI)? Wall Street Analysts Think 27.28%
How Much Upside is Left in Hesai Group Sponsored ADR (HSAI)? Wall Street Analysts Think 27.28%

Hesai Group Sponsored ADR (HSAI) closed the last trading session at $22.29, gaining 1.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Can InfuSystems Holdings (INFU) Climb 79.52% to Reach the Level Wall Street Analysts Expect?
Can InfuSystems Holdings (INFU) Climb 79.52% to Reach the Level Wall Street Analysts Expect?

InfuSystems Holdings, Inc. (INFU) closed the last trading session at $7.52, gaining 21.5% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts See a 32.98% Upside in Great Lakes Dredge & Dock (GLDD): Can the Stock Really Move This High?
Wall Street Analysts See a 32.98% Upside in Great Lakes Dredge & Dock (GLDD): Can the Stock Really Move This High?

Great Lakes Dredge & Dock (GLDD) closed the last trading session at $11.28, gaining 0.8% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts Think Contineum Therapeutics, Inc. (CTNM) Could Surge 235.81%: Read This Before Placing a Bet
Wall Street Analysts Think Contineum Therapeutics, Inc. (CTNM) Could Surge 235.81%: Read This Before Placing a Bet

Contineum Therapeutics, Inc. (CTNM) closed the last trading session at $6.73, gaining 67% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Wall Street Analysts See a 55.87% Upside in Superior Group (SGC): Can the Stock Really Move This High?
Wall Street Analysts See a 55.87% Upside in Superior Group (SGC): Can the Stock Really Move This High?

Shares of Superior Group (SGC) have gained 2.7% over the past four weeks to close the last trading session at $11.42, but there could still be a solid upside left in the stock if short-term price

Wall Street Analysts Believe Sky Harbour Group (SKYH) Could Rally 72.97%: Here's is How to Trade
Wall Street Analysts Believe Sky Harbour Group (SKYH) Could Rally 72.97%: Here's is How to Trade

Sky Harbour Group Corporation (SKYH) closed the last trading session at $10.36, gaining 1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets

Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing
Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing

Shares of Foghorn Therapeutics Inc. (FHTX) have been struggling lately and have lost 5.1% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean

Reddit Inc. (RDDT) Just Flashed Golden Cross Signal: Do You Buy?
Reddit Inc. (RDDT) Just Flashed Golden Cross Signal: Do You Buy?

After reaching an important support level, Reddit Inc. (RDDT) could be a good stock pick from a technical perspective. RDDT recently experienced a "golden cross" event, which saw its 50-day simple

Does Remitly Global (RELY) Have the Potential to Rally 43.06% as Wall Street Analysts Expect?
Does Remitly Global (RELY) Have the Potential to Rally 43.06% as Wall Street Analysts Expect?

Remitly Global, Inc. (RELY) closed the last trading session at $18.95, gaining 3.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by

After Golden Cross, Halozyme Therapeutics (HALO)'s Technical Outlook is Bright
After Golden Cross, Halozyme Therapeutics (HALO)'s Technical Outlook is Bright

Halozyme Therapeutics, Inc. (HALO) is looking like an interesting pick from a technical perspective, as the company reached a key level of support. Recently, HALO's 50-day simple moving average